A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology. [electronic resource]
- PloS one 2020
- e0226661 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0226661 doi
Adaptive Immunity--drug effects Aminoacyltransferases--antagonists & inhibitors Antigens, Differentiation--chemistry CD47 Antigen--chemistry Drug Development Gene Expression Regulation, Neoplastic--drug effects High-Throughput Screening Assays--methods Humans Immunotherapy--methods Jurkat Cells Laser Scanning Cytometry Ligands Medical Oncology--trends Neoplasms--drug therapy Phagocytosis--drug effects Protein Interaction Maps--genetics Receptors, Immunologic--chemistry Small Molecule Libraries--chemistry